Electrophysiology & Arrhythmia

Category icon
Intraventricular Conduction Disturbances After TAVI

Shu-I Lin, Mizuki Miura, Ana Paula Tagliari, et al

Category icon
Management of Valvular Disease During Pregnancy

Chiara Fraccaro, Noemie Tence, Giulia Masiero, et al

Category icon
Diagnostic Angiograms and PCI in Pregnancy

Phyo Htet Khaing, G Louise Buchanan, Vijay Kunadian,

Category icon
Device-Related Thrombus After Left Atrial Appendage Closure

Philippe Garot, Bertrand Cormier, Jérôme Horvilleur,

Category icon
Optimising Stent Deployment in Contemporary Practice: The Role of…

Ashok Seth, Sajal Gupta, Vivudh Pratap Singh, et al

Category icon
A Quick Guide to Paravalvular Leak Closure

Sameer Gafoor, Jennifer Franke, Stefan Bertog, et al

Category icon
Real World Outcomes of Left Atrial Appendage Occlusion

Apostolos Tzikas, Darren Mylotte, Martin Bergmann,

Category icon
Permanent Pacemaker Implantation after TAVR – Predictors and Impact on…

Marcel Weber, Jan-Malte Sinning, Christoph Hammerstingl, et al

About

Electrophysiology has rapidly transformed from diagnostic cardiac studies to direct therapeutic interventions. Many cardiac arrhythmias that formerly required the use of drugs or surgery can now be routinely cured in the electrophysiology laboratory by means of transcatheter ablation techniques.

Clinical electrophysiological techniques have evolved for the assessment of sinus nodal, AV nodal and His-Purkinje system function. The evaluation of tachyarrhythmias has progressed rapidly, and pharmacological, device and surgical therapy can now be guided by electrophysiology of heart and arrhythmias studies.

Supraventricular arrhythmias can exacerbate the heart failure symptoms by decreasing the effective cardiac output and control requires pharmacological, electrical or catheter-based intervention.

In patients with atrial flutter or atrial fibrillation, anticoagulation is paramount to prevent systemic or cerebral embolism. People with heart failure are also prone to develop ventricular arrhythmias that can present a challenge to the clinician. The management strategy depends on the type of arrhythmia, the underlying structural heart disease and the severity of heart failure.

Related Articles

Articles

Article icon
Intraventricular Conduction Disturbances After TAVI

Published: - Shu-I Lin, Mizuki Miura, Ana Paula Tagliari,

Citation: Interventional Cardiology Review 2020;15:e11.

Management of Valvular Disease During Pregnancy

Published: - Chiara Fraccaro, Noemie Tence, Giulia Masiero,

Citation: Interventional Cardiology Review 2020;15:e10.

Diagnostic Angiograms and PCI in Pregnancy

Published: - Phyo Htet Khaing, G Louise Buchanan, Vijay Kunadian,

Citation: Interventional Cardiology Review 2020;15:e04.

BCIS COVID-19 Statement

Published: - Nick Curzen,

Citation: Interventional Cardiology Review 2020;15:e01.